Stock Screener App

Frei -

Installieren

1.31

2.24% -0.03

Allogene Therapeutics Inc (ALLO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-07-01
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.64	-	-	-	-
Operating Expenses	11.86% 51.56	46.09	42.40	44.90	56.82
Operating Income/Loss	1.80% -46.92	-46.09	-42.40	-44.90	-56.82
Nonoperating Income/Loss	21.75% 4.243	3.485	3.594	3.501	5.876
Net Income/Loss	0.16% -42.68	-42.61	-38.81	-41.40	-50.94
Basic Average Shares	36.89% 328.93	240.29	-	222.04	218.93
Diluted Average Shares	36.89% 328.93	240.29	-	222.04	218.93
Basic Earnings Per Share	27.78% -0.13	-0.18	-	-0.19	-0.23
Diluted Earnings Per Share	27.78% -0.13	-0.18	-	-0.19	-0.23

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters